Gene Therapy
A Areas medical research research area page covering state of the field, key trials running, recent readouts and what is close to approval, alongside the 7
T Cell Therapy Treats Atopic Dermatitis
A Lancet comment published August 21, 2026, discusses rezpegaldesleukin, a novel therapy designed to expand regulatory T cells for treating
Revolution's pancreatic cancer drug Rasonque cleared by FDA
Revolution Medicines' pancreatic cancer therapy Rasonque cleared FDA approval via priority review voucher, marking a major advance for second-line...
Daraxonrasib Approved for Metastatic Pancreatic Cancer
The FDA has granted approval to the RAS inhibitor daraxonrasib for adults with metastatic pancreatic ductal adenocarcinoma who have progressed on...
TALENTOP trial: conversion surgery in advanced HCC
The TALENTOP study, a multicentre, open-label, randomised phase 3 trial, compares liver resection after atezolizumab and bevacizumab with maintenance...
Focal Therapy
Focal therapy for prostate cancer has divided physicians, with some considering it a viable alternative to traditional treatments and others viewing...
UK feasibility trial finds psilocybin therapy safe for resistant depression
A 2026 feasibility study delivering psilocybin-assisted therapy within the NHS reported high adherence and no safety concerns, raising questions...
FDA Clears Bristol Myers Squibb's Oral Multiple Myeloma Therapy, Introducing First-in-Class Agent
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients...